Urban Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Urban Wealth Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Buy	+55	New	+$2.31K	0.01%	301

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

CCMG

Clark Capital Management Group Philadelphia, Pennsylvania $18.3B AUM 36.97% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Urban Wealth Management's XPH Position: Q2 2022 in Review

Urban Wealth Management opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2022: 55 shares worth $2K. The stake represents 0.01% of the portfolio and ranks #301 among its holdings.

71 funds tracked by Wall St. Rank hold XPH as of Q2 2022.

Urban Wealth Management held 55 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2K as of Q2 2022.
State Street SPDR S&P Pharmaceuticals ETF was a new Urban Wealth Management position in Q2 2022.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Urban Wealth Management's portfolio in Q2 2022, its #301 holding.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.